Rare diseases
Investigational molecules
Locations
Back to Belgium4 clinical trials in Duffel, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Minocycline and Celecoxib for Patients with Major Depressive Disorder Not Responding to Antidepressants
BelgiumStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
BelgiumStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
BelgiumTesting BI 1569912 for Major Depressive Disorder in Patients Using Antidepressants
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Major Depressive Disorder and treatment-resistant depression, exploring novel therapeutic approaches and augmentation strategies.
Current trials are evaluating innovative treatment combinations and dosing strategies for patients who haven't achieved optimal results with standard therapies.
Comprehensive research into schizophrenia, particularly focusing on cognitive impairment and long-term treatment outcomes with novel therapeutic agents.
These studies aim to enhance our understanding of long-term treatment safety and efficacy in schizophrenia management.
Exploring immune-targeted treatments and novel pharmaceutical approaches for treatment-resistant depression, including anti-inflammatory strategies.
Research focuses on identifying and validating new treatment pathways for patients who haven't responded to conventional therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
